CXCR4 and its ligand CXCL12 may take over as suggested by the beneficial effect of a CXCR4 antagonist peptide in another mouse model of lupus (B6.Sle1Yaa; [48]). This evidence concerns the gene CXCR4 and systemic lupus erythematosus.